Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Immune Cells & Tiny Chip Delivery to Inflammation - News Directory 3

Immune Cells & Tiny Chip Delivery to Inflammation

November 14, 2025 Lisa Park Tech
News Context
At a glance
  • Pulinā Sarkar,⁢ an electrical engineer and assistant professor at ⁤the Massachusetts Institute of Technology (MIT),‌ is developing microscopic electronic devices that can be hybridized⁣ with living cells and...
  • Sarkar faced significant hurdles in ‍securing funding for her research.
  • In 2022, after‌ generating promising initial data with the ​cell-electronics hybrids, Sarkar's team submitted a⁢ proposal⁢ for the National Institutes of Health (NIH) ⁢Director's New Innovator​ Award.
Original source: arstechnica.com

MIT Engineer Pioneers Injectable Electronics for Brain Implants

Table of Contents

  • MIT Engineer Pioneers Injectable Electronics for Brain Implants
    • Overcoming Initial⁣ Skepticism
    • Breakthrough Funding and Key Achievements
    • Addressing Fundamental Challenges
    • Implications and Future Directions

Updated November 14, 2024, 8:31 AM PST

Pulinā Sarkar,⁢ an electrical engineer and assistant professor at ⁤the Massachusetts Institute of Technology (MIT),‌ is developing microscopic electronic devices that can be hybridized⁣ with living cells and injected into the bloodstream. ‍These cell-electronics hybrids are designed to travel through the circulatory system and self-implant in ⁣specific areas⁢ of the brain.This technology holds potential for targeted therapies and advanced neurological monitoring.

Overcoming Initial⁣ Skepticism

Sarkar faced significant hurdles in ‍securing funding for her research. “In the first two years of working on this technology at MIT, we’ve got 35 grant⁢ proposals⁢ rejected in a row,” Sarkar⁣ recounts. Reviewers acknowledged the ⁢potential​ impact of the work but deemed it “impossible,” likening the concept to science fiction.‍ However, ‌after over six years of dedicated‌ research, Sarkar and her team successfully​ demonstrated‌ the feasibility of their approach.

Breakthrough Funding and Key Achievements

In 2022, after‌ generating promising initial data with the ​cell-electronics hybrids, Sarkar’s team submitted a⁢ proposal⁢ for the National Institutes of Health (NIH) ⁢Director’s New Innovator​ Award. This marked the first time their⁣ work passed peer review, receiving what Sarkar described as “the highest impact‍ score ⁣ever.” The ‌ NIH Director’s new Innovator Award supports early-career ⁤investigators who propose highly innovative research.

Addressing Fundamental Challenges

The high impact score stemmed from ​the technology’s ‍ability to solve three critical challenges. The primary obstacle was creating functional electronic ‍devices smaller than cells that could safely circulate within the ‌bloodstream.Previous attempts ​focused on using magnetic particles guided⁢ by external magnetic fields, but Sarkar’s approach offers significant advantages.

“There is a difference between electronics and particles,” Sarkar explains. Electronics, specifically those ⁤built⁢ using Complementary Metal-Oxide-Semiconductor (CMOS)⁤ technology – the foundation of modern computer⁤ processors ⁣- can generate electrical power from light, ⁣similar to photovoltaic ‍cells, and perform complex computations.this capability enables clever⁤ applications⁤ like advanced sensing. ‌ Magnetic particles, in contrast, ‌are limited to cell stimulation.

CMOS technology‍ allows for ‍the creation of devices with significantly more functionality than simple particles.CMOS⁢ technology is a standard method for creating integrated circuits.

Implications and Future Directions

This ‌technology opens doors to a new era of brain-computer interfaces ⁣and targeted neurological⁤ treatments. The ability to deliver functional electronics‌ directly to specific brain regions via the bloodstream could revolutionize the treatment of conditions like Parkinson’s ⁤disease, Alzheimer’s⁢ disease, and spinal cord injuries. Further ​research will focus on refining the targeting mechanisms, ensuring long-term biocompatibility, and expanding the⁢ range ⁤of functionalities embedded within⁤ the cell-electronics hybrids.

The development‍ also highlights the importance of perseverance in scientific research. Sarkar’s story demonstrates that even seemingly “impossible” ideas can be realized with dedication and innovative thinking.

This ⁤article was last updated on November 14, 2024, to reflect the latest information available. information is based on publicly available sources ‌and statements made by Pulinā Sarkar.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service